Table 1.

Meaningful Use Objectives Relating to Ambulatory Electronic Prescribing

Health Outcomes Policy PriorityStage 1 ObjectivesStage 1 Measures
Core set
    Improving quality, safety, efficiency, and reducing health disparitiesImplement drug-drug and drug-allergy interaction checksThe EP must attest that this function is enabled for the entire reporting period
Generate and transmit permissible prescriptions electronicallyMore than 40% of all permissible prescriptions written by the EP are transmitted electronically using certified technology
Maintain an active medication listMore than 80% of all unique patients seen by the EP have at least one entry (or an indication that the patient is not currently taking any medication) recorded as structured data
Maintain an active medication allergy listMore than 80% of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data
Menu set
    Improving quality, safety, efficiency, and reducing health disparitiesImplement drug-formulary checksThe EP must attest that this function is enabled and have access to at least one drug formulary for the entire reporting period
  • EP, eligible professional.

  • Adapted from Table 2 of Ref. 13.